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Abstract
The number of pathogenic microorganisms that are capable of killing insect
pests is extremely large. Some bacteria are more attractive to researchers
developing microbial biological control agents because their genomes are
simple enabling easier study and manipulation. Several bacterial species
are already used on a large scale as control agents against some insects.
Commercial preparation of these bacteria in theform of insecticidal powders
are available for use in the field. Although thesepreparations are somewhat
more expensive and also less e/jicient than chemical insecticides, for several
reasons including recent awareness of environmental safety, development of
biological control agents has recieved increased attention of biologists.
Several varieties of Bacillus thuringiensis have been well studied for
their to:xic effects on insects. These bacteria produce proteinaceous paras-
poral crystals during their sporulation. When these crystals are ingested
by insect larvae protein protoxins are solubilised in the alkaline environment of
the insect midgut releasing polypeptides toxic to the epithelial cells resulting
in quick death of the larvae.
Toxicity of Bacillus thuringiensis var. israelensis is specific to mosquito
and blackfly larvae. However, large scale use of this bacterium for the
control of mosquitoes is limited by its low persistenee in the field after
application. Four genes coding for 4 different toxic polypeptides have been
isolated from this bacterium and all these have been cloned in E. coli and
studied. Research is being done to study the posible manipulation of these
genes in order to obtain potentially much more efficient bacterial strains for
the control of insects.
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1. General Comments
The number of pathogenic microorganisms that are capable of killing
insects is extremely large. Among them are several families of bacteria, viruses,
fungi, protozoa and nematodes. Bacteria, fungi and viruses are more attrac-
tive for exploitation as biological control agents because their genomes are
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quite simple in comparison with those of higher organisms making them easier
to study and manipulate. Genetic modifications of these microorganisms have
become day to day activities of molecular geneticists especially after the
development of the recent technology of genetic engineering. Many strains
of bacteria, fungi and viruses have already been produced commercially as
insecticides and their formulations, applications and modes of action have been
studied Strains of the bacterium Bacillus thuringiensis have undergone industrial
manufacture as a biological insecticide for world wide use against Lepi-
doptera on field crops, trees, ornamentals, vegetables, stored grain and grain
products(31)
Attempts are made to introduce the genes responsible for the toxins of
bacteria into crop plants. Successful experiments on this line have already been
performed. Tobacco plants into which d-endotoxin gene of Bacillus thurin-
giensis has been inserted using Ti plasmid of Agrobacterium tumifaciens are
protected against larvae of Manduca sexta (43).
Use of bacteria as biological control agents is not new. However, until
recently their cost of production and relatively low effectiveness in the field in
comparison with chemical insecticides prevented the growth of strong incentives
to industry to make big investments for research and development of biological
insecticides. Advantages of biological insecticides over chemical insecticides
are many. They are highly specific towards target species and are harmless
to man and environment. Since they are not effective against the natural insect
predators of the target species even the natural control methods remain intact
after the treatment. They leave no harmful residues. Because they are living
organisms they have the potential for amplification in the field by reproduction
and for reaching a steady state of eluilibrium for continued existence with
target species. Although produced by industry today they are products of
evolution and have been in contact with insects for a very long time in history.
It appears that insects cannot easily develop resistance to these biological
agents. Insects have, however, shown remarkable abilities to develop resist-
ance towards chemical agents.
Use of bacterial insscticides in the field still remain low in contrast to the
overwhelming use of chemicals because bacterial insecticides are less effective
for several reasons. They do not kill insects upon contact but must be ingested
either by feeding on the bacterium or by feeding on leaf tissues containing the
bacterium. Sometimes it is necessary or helpful to incorporate feeding at-
tractants with the agent. All developmental stages of the insects are not
equally succeptible to the pathogen and as a result the user often has to time
the application well. Some biological agents are, although highly efficient
in the laboratory, not very effective in the field. The lack of potency may be due
to reasons such as poor storage capability, requirement of specific ecological
nitches or wash off by rain. Biological activity of toxic crystal inclusions of
bacteria generally decays with a half life of about 8 days (20). Very narrow
host range of the biological agent has its disadvantages. Many worldwide
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crops have several different important insect pests with different behaviour
patterns. As there can be no biological agent that can control all of them
there is the necessity of multiple application bringing economic obstacles.
Manufacturing costs of biological agents, specially those which require expen-
sive growth media or in vivo cultres of reared insect larvae, are high.
Increased concern of the public and regulatory organisations regarding
pollution and environmental safety in reeent years has caused a more intense
attention towards biological control methods. Recent advances in recombi-
nant DNA technology provide exceptionally powerful tools for generating
entitely new and much more effective biological control agents than naturally
occuring ones. General acceptance that genetically engineered bacteria can
be used in the fields with safety has also justified the investments on new re-
search ventures. The development of safe effective and profitable biological
insecticides, however, require extensive research. Information gathered during
last few years about the structure and modes of action of the toxins produced
by insect pathogens are of utmost importance and these will lead to the deve-
lopment of genetically engineered biological insecticides in the near future.
2. Insecticidal bacteria
Over 100entomopathogenic bacteria have been identified. Most of these
belong to the families Bacillaceae, Micrococcaceae, Lactobacillaceae and
Pseudomonadaceae (31). Some species of the family Bacilliaceae such as
Bacillus sphaericus, Bacillus thuringiensis, Bacillus lentimorbus and Bacillus
popilliae and their many subspecies have received highest attention and have
been extensively studied. These bacteria produce proteinaceous parasporal
crystal inclusions, -endotoxins, during sporulation. Protein protoxins are
deposited in the inclusion and sometimes also on the surface of the spore.
When the inciusion is ingested by the insect the protoxin is solubuised in the
alkaline and reducing environment of the midgut of the larvae. The proteases
of the gut convert the protoxins into toxins which act on the recepters of the
midgut epithelial cells causing swellingand rupture of the cells. Feeding of the
insect is inhibited followed by death ocurring within fewminites after ingestion
or in some cases few days after ingestion. In vitro studies of Thomas and
Ellar (39) has shown that the toxin binds to phosphatidyl choline, spingo-
myelin and phosphatidyl ethanolamine containing unsaturated fatty acids
suggesting that in the midgut of the mosquito larvae the toxin interacts with
specificplasmam- membrane lipids leading to the disruption of members
integrity and eventual cytolysis.
The hemolymph of the insect larvae also provides an excellent nutritional
environment for the proliferation and sporulation of these bacteria (9). Toxi-
city of the crystals are specific. For example crystals of Bacillus thuringiensis
var kurstaki are toxic to certain Lepidoptera while crystals of Bacillus thurin-
giensis Var. israelensis are toxic to certain Diptera (mosquito and black fly)
and have no effecton Lepidoptera. BesidesBacillus thuringiensis Var. israelen-
sis at least two other subspecies of B. thuringiensis which are specificallyactive
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against mosquito larvae have been isolated. These are Bacillus thuringiensis
Subsp. darmstadiensis and Bacillus thuringiensis subsp. morrisoni (7). Bacillus
sphaericus also harbour inclusions which are highly toxic to mosquito larvae(12).
Aronson et al (4) gives a comparative account of the toxicity of different sub-
species of Bacillus thuringiensis.
3. Bacillus thuringiensis var. israelensis (Bti)
Bacillus thuringiensis Var. israelensis was discovered in Israel in 1977 (17)
and was defined as a new serotype H 14 of Bacillus thuringiensis in 1978 (13).
Its specific toxicity towards larvae of many species of mosquitoes and black
fiy has been well established. In a comparative study made with laboratory-
rared and field-collected mosquito larvae of several species (38) it has been
shown that 2nd instar larvae of Aedes aegypti to be the most sensitive with a
LC50 in 24h to be 2.5xI02 organisms '1Y\1. 2nd instar larvae of Culex quinque-
faciatus. Aedes albopictus Culex mimutas, Cules vishnui are also very sensitive.
3rd instar larvae of Anopheles dirus, 2nd instar and 3rd instar larvae of Ano-
pheles vagus, 3rd instar larvae of Anopheles masculatus and Armigeres sabal-
batus, 2nd instar larvae of Culex tritaentiorthynchus were relatively less sensi-
tive. 3rd instar larvae of Toxorhynchites splendens and 4th instar larvae of
Mansonia uniformis and Mansonia indiana were not suseptible.
Bacillus thuringiensis produced by fermentation can be formulated as a
stabilised emulsion, wettable powder or dust containing a mixture of spores,
toxin crystals and particulate debris. Toxicological tests of these preparations
on humans have been performed using large does applied by all conventional
routes such as oral respiratory, subcutaneous, skin surface, eye cavity etc. (9)
Inspite of its high potential, use of Bti in the field remain limited. Main
reason for this is because of its low persistence in the field after application.
The bacterium has not been found to reproduce in natural bodies of water
and does not reach environmental steady states with lowered populations of
the target species as in case of many other biological control agents. Its toxic
effect disappear from mosquito breeding habitats within 24-48 h of application
due to absorption of spores to silt particles or due to other reasons (29)
In a field experiment (30) repeated biweekly application of Bti to ditches
has effectively controlled the population of Culex quinquefaciatus. In this
study newly hatched larvae have been observed one day after the treatment of
the ditches with Bti indicating that Bti spores remain in the feeding zone of
larvae only about one day after application.
Arieh Zaritsky et al. (2) have shown in laboratory experiments that mini-
mal number of Bti spores need to be ingested to kill one 3rd instar larvae of
Aedes aegypti is about 1000. However, after the death of the larva the spores
germinate and multiply in the carcass and several days later 3-4 XI06 spores
accumulate in a single carcass. Spores are observed inside the carcass micros-
copically 30 h after the death although not after 24 h (3). Thus some amount
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of amplification of the pathogen can take place in nature after treatment.
Arieh Zaritsky, et al have also shown that in the laboratory condition larvae of
Aedes aegypti feed on the carcass of its own species killed by Bti spores causing
cycles of deaths among larvae. Their observations suggested the possibility of
using Bti killed larvae as an encapsulating agent and a more effective delivery
agent for Bti spors. However the extent to which the mosquito larvae feed
on the carcass of deead mosquito lavae in their natural habitats is unknown.
4. Plasmidsof Bti
Bti has been variously reported to contain 5, 7, 8 or 9 plasmids. Their
sizes range from 3 to 130 MDa. Ward and Ellar (45) by analysis of over 100
isolates cured of one or more of the 9 plasmids, revealed that the loss of 72
MDa plasmid was invariably accompanied by loss of the ability to synthesise -
endotoxin protein. Deletion of one or more of any other plasmid did not
have any effect on the endotoxin production. Thus the genes responsible for the
production of - endotoxins are carried in a 72 MDa plasmid and not in others.
However, according to one report a 135MDa plasmid seem to be necessary for
the transfer of 72 MDa plasmid (18).
Apart from the 72 MDa plasmid the functions of the other plasmids are
not known. Clark et al (II) have studied three of these plasmids of the sizes
5.4 kb, 6. 51 kb and 7.53 kb. and prepared restriction endonuclease site maps
of them. Small plasmids of Bti may be useful in the construction of shuttle
vectors for E. coli, B. subtilis and Bti. Miteva and Grigorova prepared res-
triction maps of three small plasmids of sizes 3.65, 4.65 and 5.5 MDa (33) and
constructed ~ 7.4 MDa plasmid by the recombination of the 3.65 MDa plas-
mid with the E. coli plasmid pJH 101(32). Mahillon et al (28) have cloned two
Bti cryptic plasmids of 9.2 kb and 10.6 kb in their entirety in pBR322.
5. Protoxio
Bacillus thuringiensis and its various subspecies and varieties produce
potent insoluble crystal toxins when the cells sporulate. In Bacillus thurin-
giensis Var. israelensis -endotoxin crystals are deposited outside exosporium
during stage II and III of sporulation (41). There are 2 t04 inclusions per cell
which are cuboidal, bipyramidal, ovoid or amorphous (46). They are 0.1 to
0.5 urn in size and are visible in sporulating cells under phase contrast micros-
cope. The crystals account for 20-30% of the dry weight of the sporulated
cells (1).
Protoxins of different varieties of Bacillus thuringiensis appear to have
different shapes of crystals, molecular weights, peptide maps, aminoacid com-
positions, carbohydrate contents and immunological cross reactivities (31).
-endotoxin genes of Bacillus thurlngiensis var herliner 1715 have been
transferred to Bti through B. suhtilis(21). In the resulting strains both her/iner
toxin active on Lepidoptera and israelensis toxin active on Diptera were ex-
pressed in normal amounts confirming that two different toxins can be har-
boured in the same bacterial strain.
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It is believed that in the midgut of the insect, where alkaline conditions
prevail, the crystals are solubilised releasing soluble glycoprotein protoxins
which are then activated by proteolytic cleavage to yield toxic polypeptides of
smaller sizes (1,27,31). Most important product appear to be a polypeptide
of 60-70 kDa which can account for most of the toxicity associated with the
crystal. Treatment of purified protoxin with trypsin or insect midgut juice
produces an active toxin of similar size.
It the invitro studies of the crystals three main components with approxi-
mate molecular weights 28 kDa, 68 kDa and 130 kDa have been identified and
studied. Molecular weights calculated by different workers for these components
seem to be slightly different. Although all these components appear to have
mosquitocidal activity each has different LC50 values. The 28 kDa compon-
ent is responsible for cytolytic and hemolytic activities. 130 kDa polydeptide
appear to be processed further in the midgut of the larvae releasing 60-70 kDa
polypeptides (5, 25, 44, 46). In some reports 4 major polypeptides with mole-
cular sizes of about 135 kDa, 70 kDa, 38 kDa and 28 kDa and some minor
species have been identified (42).
Pfannenstial et. al (34) tested the immunological relatedness between
different polypeotides of the crystal and found that although 135, 70 and 28
kDa fractions are immunologically distinct 38 kDa species is derived from
70 kDa protein by proteolysis (34).
Cheung et al., (10) isolated a 25 kDa protein by solubilising the crystals
at pH II followed by anion exchange chromatography. This protein, although
it had strong cytolytic activity showed no mosquitocidal activity either in the
solubilissd form or when the protein was absorbed into latex beads. This
suggested that cytolytic component of the crystal is not insecticidal and that
different components do not act alone.
Most of the studies favours the view that there are probably three gene
products in the crystal. The three genes appear to code for products of the
ranges 55-70, 125~135 and 25-30 kDa. Garduno et. al, cloned a toxin gene
from Bti in E. coli and in Bacillus subtilis. A 58 kDa gene product was mosquito-
cidal to larvae of Aedes aegypti (40). When this gene was introduced into a
crystal negative mutant of Bti partial toxicity was restored (16). This 58 kDa
component of the crystal is structurally related to 130 kda component. The
gene for the 130 kDa component has also been cloned and expressed (37).
Evidence has been found (6) to indicate that the two- genes coding for the two
polypeptides of 135akDa and 58 kDa are both found in the 72 MDa plasmid of
Bti and are separated physically by as few as 2000 base pairs. The smaller
gene of the two is perhaps derived from the bigger one.
6. Endotoxin genes.
The isolation, cloning and characterisation of protoxin genes could result
in the development of more potent Bti toxins. Pro toxin genes of most of the
Bacillus species appear to be located in plasmids of various sizes. All such
plasmids are however greater than 35-MDa. There seems to be conserved
regions of DNA in plasmids of different subspecies. The location of the
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protoxin genes in plasmids also seems to be related to the presence of inverted
repeat elements providing a mobilising capacity. Gonsalez and Carlton (18)
have found from the study of plasmid profiles of var. israelensis that some
spontaneous derivatives lost the protoxin encoding plasmid of 75-MDa.
However, sequences hybridising with the plasmid were found in the chromoso-
mal DNA. The derivatives were still -oxic to larvae indicating that protoxin
gene expression takes place after integration to the chromosome. Derivatives
of this strain were the toxic sequences where found in new plasmids of 65-80
MDa were also found. These results and subsequent studies with sequence
probes indicated that protoxin genes are located on a transposable element.
Detailed mapping and electron microscopic analysis have shown that in the
host plasmid the toxin gene is flanked by multiple copies of two repeated DNA
elements (23-26-8).
Protoxin genes of Bacillus thuringiensis var kustaki (19,36), var. berliner(22),
var. israelensis as well as B. sphaericus(15) have been cloned. Partial nucleotide
sequence also have been elucidated in some cases. It is believed that the pro-
moter of the toxin gene is conserved in different subspecies of Bt. It has been
shown that transcription is initiated from two overlapping promoters. One
of them is utilised in early stages of sporulation while the other one, located
upstream, is utilised four hours after the onset of sporulation (35). Termina-
tor region of the crystal protein gene stabilises the m-RNA. This stability is
partly responsible for the abundant synthesis of the protein (23).
One important approach to the study would be the location of the nucleo-
tide sequence for the ultimate active toxic polypeptide within the larger pro-
toxin gene. To achieve this goal it is necessary to study the complete nucleo-
tide of the gene, aminoacid sequence and the molecular weight of the poly-
peptide required Restriction enzymes and endonucleases can be used to frac-
tionate the genes and each fraction can be cloned in expression vectors which
can be used to transform bacteria. Extracts of the transformed bacteria can
be screened for toxicity in bioassays. Cloning of the active region of the gene
will provide a probe that can be used to scan the total plasmid DNA of different
strains. In a study of this nature done with the pro toxin gene of the variety
kurstaki (24), a single 732 bp restriction fragment has been used as a hybridi-
sation probe for analysing 17 insecticidal strains of 9 subspecies of Bacillus
thuringiensis. The probe has hybridised with DNA from strains toxic to Lep-
idoptera but failed to hybridise with DNA from subspecies toxic to Diptera.
Hybridisation experiments conducted with 28 kDa protein gene and the 130
kDa protein gene of the Bti have shown that these two genes are probably
present in the plasmid DNA of Bacillus thuringiensis subsp. morrison; which
is also highly active against mosquito larvae (7)
Another line of study would be to compare the aminoacid sequence of
protoxins produced by different varieties having different host ranges or to
compare the nucleotide sequences of the genes coding for them. This type of
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study will elucidate the presence of conserved and variable regions within toxin
genes of different subspecies. These in turn will relate the structure to biolo-
gical activity. Conserved and variable regions of the genes can also be elu-
cidated in nucleic acid hybridisation studies. A study of structure-function
relationships of the toxin polypeptide will enable genetic redesigning of the
molecules to obtain a more potent toxin. Site directed mutagenesis could be
used to make precise changes required and intragenic hybridisation between
different strains could be used to obtain combination of characters found in
different genes to produce more potent combinations (20)
The synthesis of toxic crystal takes place naturally only at the onset of
sporulation of the bacterium. By fusing the structural gene sequence to a
strong constitutive promoter it may be possible to make bacteria to produce the
toxin throughout their life cycle in large amounts making the process more
economical. Such cells may not lyse spontaneously to liberate toxin to en-
vironment. An artificcial lysis step can then be introduced in the manu-
facturing processes (20)
Much information has been gathered during the last few years on the
toxin genes and their function. Much research remains to be done. Most of
the rzsearch are directed towards creation of genetically redesigned genes and
plasmids capable of producing much more potent mosquitocide toxins than
those found in nature. When the researchers reach this success it would be
another important achievement in the field of recombinant DNA technology.
The developing countries like Sri Lanka, and others in the South East Asia
and those in Africa and South America where mosquito borne diseases are a
major health problem could benefit immensely from such studies.
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